COVID-19 Vaccination Considerably Reduces Risks for Pregnant Women, Canadian Study Finds

A large-scale Canadian study confirms that COVID-19 vaccination offers significant protection to pregnant women, lowering their risk of hospitalization, intensive care, adn premature birth. The findings underscore the importance of vaccination for both those planning a pregnancy and those currently expecting.

A team of researchers from the Canadian COVID-19 Surveillance Program in Pregnant Women (CANCOVID-Preg), led by the University of British Columbia, analyzed health records and clinical reports from nearly 20,000 pregnant women diagnosed with COVID-19 between April 5, 2021, and December 31, 2022. The study encompassed cases involving both the Delta and Omicron variants across eight Canadian provinces and one territory.

Dramatic Reduction in Severe Outcomes

The research revealed a compelling correlation between vaccination status and health outcomes. According to the study’s lead author, Deborah Money, a professor of obstetrics and gynecology at the University of British Columbia, the data “confirmed the benefits of COVID-19 vaccination for pregnant women.” Vaccinated pregnant women experienced approximately a 60% reduction in the risk of hospitalization compared to their unvaccinated counterparts. Furthermore, the risk of requiring intensive care was a remarkable 90% lower in vaccinated individuals.

Lower Rates of Premature Birth

Beyond reducing the severity of illness, the study also demonstrated a significant impact on pregnancy outcomes. Vaccinated women exhibited a 20% lower risk of premature birth during the period when the Delta variant was dominant. This protective effect was even more pronounced during the Omicron wave, with a 36% reduction in premature births among vaccinated women.

Interestingly, researchers discovered that receiving the COVID-19 vaccine during pregnancy offered a greater reduction in premature birth rates than vaccination prior to becoming pregnant. This finding highlights the potential benefits of vaccination at any stage of pregnancy.

Ongoing Protection Remains Crucial

Despite the current lower prevalence of COVID-19 in Canada, experts emphasize the continued importance of vaccination.”It is never too late to get vaccinated,” Money stated, advising that women planning a pregnancy or who are currently pregnant should receive the vaccine, including any recommended boosters. This proposal is based on the enduring protection offered by the vaccine and the potential for future surges or the emergence of new variants.

The findings from this thorough study provide further evidence supporting the safety and efficacy of COVID-19 vaccines for pregnant women, reinforcing public health recommendations and offering reassurance to expectant mothers.

Why, Who, What, and How did it end?

Why: The study was conducted to determine the impact of COVID-19 vaccination on pregnant women and their pregnancy outcomes.

Who: The study was led by Deborah Money of the University of British Columbia and involved researchers from the Canadian COVID-19 Surveillance Program in Pregnant Women (CANCOVID-Preg). Nearly 20,000 pregnant women across eight Canadian provinces and one territory were analyzed.

What: The study found that COVID-19 vaccination significantly reduced the risk of hospitalization (60%), intensive care (90%), and premature birth (20-36% depending on the variant). Vaccination during pregnancy offered greater protection against premature birth than vaccination before pregnancy.

How did it end? the study concluded on December